Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1FED 1

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 2Stress Disorders, Post-Traumatic 1Motor Activity 1Advanced Cancer 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Coping Skills × Clear all
NCT04889755 2025-02-17

R03 CA259898

Boston University Charles River Campus

Phase NA Completed
6 enrolled 22 charts

Neoplasms, Stress Disorders, Post-Traumatic

NCT00740038 2017-02-23

Support for People Undergoing Chemotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
471 enrolled

Motor Activity, Neoplasms

NCT01444157 2014-07-18

FamCope

Bispebjerg Hospital

Phase 3 Completed
700 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡